Skip to content
Disclosery

EXANE DERIVATIVES: OMC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on OMC, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 996 OMC shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 996 shares
    Change vs previous 13F +95 shares

    0.04% of the 13F portfolio, value $63,349.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 901 shares
    Change vs previous 13F -101 shares

    0.02% of the 13F portfolio, value $76,478.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,002 shares
    Change vs previous 13F +985 shares

    0.02% of the 13F portfolio, value $73,420.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 17 shares
    Change vs previous 13F -7,694 shares

    <0.01% of the 13F portfolio, value $1,232.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 7,711 shares
    Change vs previous 13F -6,993 shares

    0.14% of the 13F portfolio, value $600,626.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 14,704 shares
    Change vs previous 13F +5,829 shares

    0.33% of the 13F portfolio, value $1,090,361.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 8,875 shares
    Change vs previous 13F -10,088 shares

    0.17% of the 13F portfolio, value $553,563.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 18,963 shares
    Change vs previous 13F not available

    0.31% of the 13F portfolio, value $938,694.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).